FridayAug 21, 2026 11:15 am

Frontieras North America Inc. Positions Domestic Coal as America’s Answer to Energy Supply Disruption

The United States sits on a significant coal resource base. FASForm produces six commercial outputs from a single coal input: diesel, naphtha, jet fuel, ammonium sulfate fertilizer, sulfuric acid and FASCarbon(TM). Frontieras is moving this technology from development into construction. The Strait of Hormuz closure that began in late February 2026 removed more than 11 million barrels of Middle Eastern crude per day from global markets and sent Brent crude from roughly $62 a barrel in December 2025 to more than $117 by April 2026. Diesel and jet fuel wholesale prices are forecast to rise more than 60% in 2026…

Continue Reading

WednesdayAug 19, 2026 10:00 am

Mathematical Study Offers Possible Fix to Melanoma Therapy Mystery

A mathematical study published in the journal Mathematical Business may have just offered a possible solution to a long-standing mystery in melanoma treatment. This is a skin cancer that starts in melanocytes, the cells responsible for determining skin color, and it typically occurs due to exposure to ultraviolet (UV) light rays from the sun and tanning beds. Although the condition is very treatable when discovered early, one mystery regarding melanoma therapy has stumped researchers for years. Studies have indicated that periodically halting the delivery of specific targeted drugs can restrain drug-resistant melanoma cells. However, experiments with intermittent dosing have shown…

Continue Reading

MondayAug 17, 2026 10:00 am

China Releases Plan to Modernize Coal Industry in 5 Years

Beijing has revealed a plan to modernize the country’s coal industry over the next 5 years. Published by the National Energy Administration and the National Development and Reform Commission, the plan will see China speed up the upgrading and optimization of the domestic coal industry during the 15th Five-Year Plan period.  This is a development blueprint approved in March 2026 as a framework for Chinese economic and social growth for the rest of the decade, culminating in 2030 when coal consumption in China is predicted to peak.  As Chinese energy demand continues to rise, and China installs record levels of new renewable capacity every year,…

Continue Reading

WednesdayAug 12, 2026 10:00 am

Researchers Use AI to Create Viruses with Possible Therapeutic Applications

A multi-institutional research team has published a paper that has increased hopes about the role of artificial intelligence in advancing medicine, but also raised questions about the dangers represented by cutting-edge technologies like AI. In a paper published in the journal Science, researchers from Harvard, the Broad Institute of MIT and Stanford University outlined how they used artificial intelligence alongside a bacteria-infecting virus to generate thousands of new virus genomes.  According to the researchers, they were left with 16 ‘viable’ viruses after chemically synthesizing most of the new genomes and testing them in sterile lab conditions. Surprisingly, the researchers found that some of the synthetic viruses killed…

Continue Reading

MondayAug 10, 2026 10:00 am

Focused Ultrasound Shows Promise in Treating Brain Tumors 

Scientists at the University of Virginia have discovered that deadly brain tumors may be more susceptible to focused ultrasound than previously thought. Research conducted at the university’s Focused Ultrasound Cancer Immunotherapy Center found that cancer drugs delivered via sound waves could be more effective in treating gliomas than conventional brain cancer treatments.  The research opens the door to targeted brain cancer treatments that cause less harm to neighboring healthy cells. Study co-author and co-director of the Ultrasound Cancer Immunotherapy Center Richard J. Price says the research team’s findings could have a notable impact on oncology.  The findings gave his research team deeper insight into…

Continue Reading

WednesdayAug 05, 2026 10:00 am

Existing Immune Protein May Boost Immunotherapy Against Cancer

Nagoya University researchers have discovered an ancient protein that occurs naturally in a wide variety of animals and has the potential to make immunotherapy treatments more effective. C3, a protein produced in the liver, typically helps the body fight off infections. However, when the protein is produced by cells within a tumor, it seems to act against immunosuppressive cells, making tumors more susceptible to immunotherapy. The researchers believe inducing C3 creation in tumors with low C3 levels could make immunotherapy more effective at eradicating cancerous cells from the body. Lead study author Yuki Miyai, an assistant professor at Nagoya University’s…

Continue Reading

TuesdayAug 04, 2026 9:00 am

Azio AI Holdings Inc. (NASDAQ: AZIO) Is ‘One to Watch’

AZIO AI is building an integrated technology infrastructure platform focused on AI data centers, enterprise GPU compute, high-performance computing and digital power solutions. In July 2026, the company completed its merger with AZIO AI Corporation and subsequently changed its corporate name and Nasdaq ticker symbol from EVTV to AZIO, completing its transformation into a dedicated AI infrastructure company. AZIO AI has announced a $27.9 million AI infrastructure and capacity agreement with Power Champion Investment Limited that is scalable to as much as $100 million as deployment expands. The company has reported receiving initial deposits under the agreement. The company recently…

Continue Reading

MondayAug 03, 2026 10:00 am

Coal Imports into Asia Continue Their Rebound

Thermal coal imports into Asia have surged for the third consecutive month, backed by summer demand from Japan, South Korea, and other major players. Despite the region’s notable commitment to renewables, Asia currently consumes nearly 90% of global seaborne thermal coal.  China undoubtedly leads the pack thanks to its energy-intensive manufacturing hubs, with experts predicting the country’s thermal coal imports will reach 28.14 million tons this month, up from 24.1 million last July.  Commodity analyst Kpler predicts Asia’s seaborne thermal coal imports will hit 73.16 million metric tons in July, jumping nearly 3 million tons from last month. Coal mostly serves as a source of electricity for many Asian nations…

Continue Reading

WednesdayJul 29, 2026 10:00 am

Tech Firms and Lawmakers Are Increasingly Worried About AI Distillation

As Chinese artificial intelligence (AI) continues to pressure leading Western models, lawmakers and industry leaders are becoming increasingly worried about AI distillation. The concept gained mainstream attention in early 2026 when Jeff Dean, the AI lead at Google, appeared on a podcast where he discussed the company’s efforts to improve its models.  He noted that distillation is a method AI firms can use to boost the capabilities of their smaller models, typically by distilling a broader model down into a smaller one. Months later, AI distillation has become a trending topic across Washington, D.C., and Silicon Valley amidst advances in Chinese AI.  Moonshot AI, a Beijing-based lab formed in 2023,…

Continue Reading

MondayJul 27, 2026 10:00 am

Experimental Immunotherapy Offers Hope Against Deadly Pediatric Brain Cancer

Research published in the journal Nature Medicine has revealed that experimental immunotherapy may provide some relief to patients with aggressive pediatric cancers. Spinal cord and brain tumors tend to have the most detrimental effects on pediatric patients, but current treatment protocols often have low success rates.  The experimental treatment from researchers at Children’s National Hospital could open the door to more effective cancer treatments for children afflicted with deadly brain cancers. Dubbed tumor-associated antigen (TAA) T cell therapy, this experimental treatment has already gone through early-stage clinical trials with encouraging results.  Several pediatric cancer patients who went through the therapy have been declared cancer-free and have remained so years after…

Continue Reading

Contact us: (512) 354-7000